GGrantIndex
← Leaderboards

Eric N Olson

Ut Southwestern Medical Center

$45,475,240
Attributed
$55,483,102
Total exposure
31
Grants
24
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.3M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$75,941,587 · 35

By mechanism

R01$27,174,300 · 10
P50$17,042,558 · 8
U54$15,547,028 · 7
U01$8,305,794 · 1
P01$3,907,807 · 4
R37$3,662,890 · 1

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingCardiacBaseHeartGene ExpressionGenesFamilyTranscription FactorMyocardiumMuscleSignal TransductionInsightAdultGenome EditingCardiac MyocytesDuchenne Muscular DystrophyFoundationsMuscular DystrophiesProteinsCellsLoss Of FunctionDystrophinMuscle CellsMolecular

Grant awards (150)

Transcriptional Control of Neonatal Heart Regeneration$565,036
R01 · FY2025 · HL · contact PI
The role of nuclear envelope protein NET39 in skeletal muscle function and diseases$422,136
R01 · FY2025 · AR · contact PI
T-Cell-Mediated Inflammatory Response in Neonatal Heart Regeneration$409,984
P01 · FY2025 · HL · contact PI
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2024 · HD · contact PI
Transcriptional Control of Neonatal Heart Regeneration$553,736
R01 · FY2024 · HL · contact PI
Project 1$532,885
P50 · FY2024 · HD · contact PI
The role of nuclear envelope protein NET39 in skeletal muscle function and diseases$454,969
R01 · FY2024 · AR · contact PI
T-Cell-Mediated Inflammatory Response in Neonatal Heart Regeneration$311,601
P01 · FY2024 · HL · contact PI
Administrative Core$162,750
P50 · FY2024 · HD · contact PI
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2023 · HD · contact PI
Transcriptional Control of Neonatal Heart Regeneration$565,036
R01 · FY2023 · HL · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$544,997
R01 · FY2023 · HL · contact PI
Project 1$532,885
P50 · FY2023 · HD · contact PI
The role of nuclear envelope protein NET39 in skeletal muscle function and diseases$469,040
R01 · FY2023 · AR · contact PI
T-Cell-Mediated Inflammatory Response in Neonatal Heart Regeneration$410,000
P01 · FY2023 · HL · contact PI
Administrative Core$162,750
P50 · FY2023 · HD · contact PI
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2022 · HD · contact PI
Transcriptional Control of Neonatal Heart Regeneration$565,036
R01 · FY2022 · HL · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$544,997
R01 · FY2022 · HL · contact PI
Project 1$532,885
P50 · FY2022 · HD · contact PI
Administrative Core$162,750
P50 · FY2022 · HD · contact PI
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2021 · HD · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$544,997
R01 · FY2021 · HL · contact PI
Project 1$532,885
P50 · FY2021 · HD · contact PI
Administrative Core$162,750
P50 · FY2021 · HD · contact PI
Myoediting of Duchenne Muscular Dystrophy$1,600,891
P50 · FY2020 · HD · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$544,997
R01 · FY2020 · HL · contact PI
Project 1$531,261
P50 · FY2020 · HD · contact PI
Administrative Core$162,253
P50 · FY2020 · HD · contact PI
Myoediting of Duchenne muscular dystrophy$1,569,794
U54 · FY2019 · HD · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$566,796
R01 · FY2019 · HL · contact PI
Myoediting Core$442,550
U54 · FY2019 · HD · contact PI
Coupling molecular and clinical phenotypes with iPSC disease modeling for myoediting of Duchenne muscular dystrophy$429,337
U54 · FY2019 · HD · contact PI
Molecular Dissection of Myoblast Fusion In Muscle Development and Regeneration$356,400
R01 · FY2019 · AR · contact PI
Correction of muscular dystrophy in mice by CRISPR/Cas9-mediated genomic editing$165,131
U54 · FY2019 · HD · contact PI
NRSA Training Core$154,173
U54 · FY2019 · HD · contact PI
Admin Core$151,920
U54 · FY2019 · HD · contact PI
Myoediting of Duchenne muscular dystrophy$1,569,794
U54 · FY2018 · HD · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$566,796
R01 · FY2018 · HL · contact PI
Myoediting Core$517,240
U54 · FY2018 · HD · contact PI
Coupling molecular and clinical phenotypes with iPSC disease modeling for myoediting of Duchenne muscular dystrophy$501,797
U54 · FY2018 · HD · contact PI
Molecular Dissection of Myoblast Fusion In Muscle Development and Regeneration$356,400
R01 · FY2018 · AR · contact PI
Correction of muscular dystrophy in mice by CRISPR/Cas9-mediated genomic editing$193,002
U54 · FY2018 · HD · contact PI
NRSA Training Core$180,193
U54 · FY2018 · HD · contact PI
Admin Core$177,562
U54 · FY2018 · HD · contact PI
Myoediting of Duchenne muscular dystrophy$1,569,794
U54 · FY2017 · HD · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$566,796
R01 · FY2017 · HL · contact PI
Myoediting Core$517,240
U54 · FY2017 · HD · contact PI
Coupling molecular and clinical phenotypes with iPSC disease modeling for myoediting of Duchenne muscular dystrophy$501,797
U54 · FY2017 · HD · contact PI
Molecular Dissection of Myoblast Fusion In Muscle Development and Regeneration$356,400
R01 · FY2017 · AR · contact PI
Correction of muscular dystrophy in mice by CRISPR/Cas9-mediated genomic editing$193,002
U54 · FY2017 · HD · contact PI
NRSA Training Core$180,193
U54 · FY2017 · HD · contact PI
Admin Core$177,562
U54 · FY2017 · HD · contact PI
Myoediting of Duchenne muscular dystrophy$1,568,584
U54 · FY2016 · HD · contact PI
Deciphering the role of a novel micropeptide in cardiac function and dysfunction$554,826
R01 · FY2016 · HL · contact PI
Myoediting Core$516,841
U54 · FY2016 · HD · contact PI
Coupling molecular and clinical phenotypes with iPSC disease modeling for myoediting of Duchenne muscular dystrophy$501,411
U54 · FY2016 · HD · contact PI
Metabolic Control by Myogenic MicroRNAs, Mediator and Myokines$477,000
R01 · FY2016 · DK · contact PI
Molecular Dissection of Myoblast Fusion In Muscle Development and Regeneration$355,392
R01 · FY2016 · AR · contact PI
Correction of muscular dystrophy in mice by CRISPR/Cas9-mediated genomic editing$192,853
U54 · FY2016 · HD · contact PI
NRSA Training Core$180,055
U54 · FY2016 · HD · contact PI
Admin Core$177,424
U54 · FY2016 · HD · contact PI
Myoediting of Duchenne muscular dystrophy$1,564,956
U54 · FY2015 · HD · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,241,255
U01 · FY2015 · HL
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis$619,723
R01 · FY2015 · HL · contact PI
Heart Repair through Reprogramming of Cardiac Cell Fate$523,307
R01 · FY2015 · HL · contact PI
Myoediting Core$515,645
U54 · FY2015 · HD · contact PI
Coupling molecular and clinical phenotypes with iPSC disease modeling for myoediting of Duchenne muscular dystrophy$500,249
U54 · FY2015 · HD · contact PI
Metabolic Control by Myogenic MicroRNAs, Mediator and Myokines$477,000
R01 · FY2015 · DK · contact PI
Molecular Dissection of Myoblast Fusion In Muscle Development and Regeneration$350,347
R01 · FY2015 · AR · contact PI
Correction of muscular dystrophy in mice by CRISPR/Cas9-mediated genomic editing$192,405
U54 · FY2015 · HD · contact PI
Admin Core$177,012
U54 · FY2015 · HD · contact PI
NRSA Training Core$120,764
U54 · FY2015 · HD · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,171,517
U01 · FY2014 · HL
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis$631,119
R01 · FY2014 · HL · contact PI
Heart Repair through Reprogramming of Cardiac Cell Fate$520,652
R01 · FY2014 · HL · contact PI
Metabolic Control by Myogenic MicroRNAs, Mediator and Myokines$477,000
R01 · FY2014 · DK · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,138,045
U01 · FY2013 · HL
MicroRNA Control of Cardiac Gene Expression, Function and Disease$556,317
R01 · FY2013 · HL · contact PI
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis$528,320
R01 · FY2013 · HL · contact PI
Heart Repair through Reprogramming of Cardiac Cell Fate$505,777
R01 · FY2013 · HL · contact PI
Metabolic Control by Myogenic MicroRNAs, Mediator and Myokines$473,800
R01 · FY2013 · DK · contact PI
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis$30,078
R01 · FY2013 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,195,425
U01 · FY2012 · HL
MicroRNA Control of Cardiac Gene Expression, Function and Disease$586,621
R01 · FY2012 · HL · contact PI
Deciphering a Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis$555,188
R01 · FY2012 · HL · contact PI
Heart Repair through Reprogramming of Cardiac Cell Fate$530,858
R01 · FY2012 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,192,208
U01 · FY2011 · HL
MicroRNA Control of Cardiac Gene Expression, Function and Disease$533,125
R01 · FY2011 · HL · contact PI
Genetic Dissection of Cardiogenesis$512,063
R01 · FY2011 · HL · contact PI
MicroRNA Control of Cardiac Gene Expression, Function and Disease$51,048
R01 · FY2011 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,178,205
U01 · FY2010 · HL
Control of Cardiac Gene Expression Through Regulated Transcriptional Coactivators$657,720
R01 · FY2010 · HL · contact PI
MicroRNA Control of Cardiac Gene Expression, Function and Disease$538,510
R01 · FY2010 · HL · contact PI
Genetic Dissection of Cardiogenesis$517,235
R01 · FY2010 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,189,139
U01 · FY2009 · HL
Control of Cardiac Gene Expression Through Regulated Transcriptional Coactivators$651,596
R01 · FY2009 · HL · contact PI
MicroRNA Control of Cardiac Gene Expression, Function and Disease$549,500
R01 · FY2009 · HL · contact PI
Genetic Dissection of Cardiogenesis$527,790
R01 · FY2009 · HL · contact PI
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$369,790
R37 · FY2009 · HL · contact PI
Control of Cardiac Gene Expression Through Regulated Transcriptional Coactivators$619,968
R01 · FY2008 · HL · contact PI
Genetic Dissection of Cardiogenesis$527,790
R01 · FY2008 · HL · contact PI
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$369,790
R37 · FY2008 · HL · contact PI
Genes that Regulate Heart Development$665,143
P01 · FY2007 · HL · contact PI
Control of Cardiac Gene Expression Through Regulated Transcriptional Coactivators$614,195
R01 · FY2007 · HL · contact PI
Genetic Dissection of Cardiogenesis$509,140
R01 · FY2007 · HL · contact PI
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$369,790
R37 · FY2007 · HL · contact PI
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$146,748
U54 · FY2007 · GM · contact PI
Cardiac Gene Expression:Trascriptional Coactivators$614,115
R01 · FY2006 · HL · contact PI
Genes that Regulate Heart Development$511,399
P01 · FY2006 · HL · contact PI
Genetic Dissection of Cardiogenesis$509,076
R01 · FY2006 · HL · contact PI
Transcriptional control of muscle growth and remodeling$384,570
P01 · FY2006 · HL · contact PI
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$380,835
R37 · FY2006 · HL · contact PI
Genetic Dissection of Cardiogenesis$506,139
R01 · FY2005 · HL
Genes that Regulate Heart Development$496,501
P01 · FY2005 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$390,000
R37 · FY2005 · HL
Transcriptional control of muscle growth and remodeling$374,195
P01 · FY2005 · HL
Genetic Dissection of Cardiogenesis$501,400
R01 · FY2004 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$334,074
R37 · FY2004 · HL
Laser Microdissection System$150,605
S10 · FY2004 · RR
LASER MICRODISSECTION SYSTEM: CARDIAC RESEARCH &DEVELOPMENT$82,832
S10 · FY2004 · RR
LASER MICRODISSECTION SYSTEM:NEURAL &MUSCLE DEV;ADULT MOUSE STEM CELLS$45,182
S10 · FY2004 · RR
LASER MICRODISSECTION SYSTEM: PANCREAS DEVELOPMENT$22,591
S10 · FY2004 · RR
MOLECULAR BASIS FOR HYPOPLASTIC HEART SYNDROMES$1,104,165
P50 · FY2003 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$390,000
R37 · FY2003 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$44,611
R37 · FY2003 · HL
MOLECULAR BASIS FOR HYPOPLASTIC HEART SYNDROMES$1,144,950
P50 · FY2002 · HL
Transcriptional control of muscle growth and remodeling$344,414
P01 · FY2002 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC HYPERTROPHY$312,000
R01 · FY2002 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$312,000
R37 · FY2002 · HL
TRANSCRIPTIONAL CONTROL OF VENTRICULAR DEVELOPMENT$186,685
P50 · FY2002 · HL
CORE--MOUSE LABORATORY$186,685
P50 · FY2002 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$78,000
R37 · FY2002 · HL
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2002 · GM
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2002 · GM
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2002 · GM
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2002 · GM
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2002 · GM
MOLECULAR BASIS FOR HYPOPLASTIC HEART SYNDROMES$1,111,933
P50 · FY2001 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$312,000
R37 · FY2001 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC HYPERTROPHY$312,000
R01 · FY2001 · HL
TRANSCRIPTIONAL CONTROL OF VENTRICULAR DEVELOPMENT$186,685
P50 · FY2001 · HL
CORE--MOUSE LABORATORY$186,685
P50 · FY2001 · HL
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2001 · GM
CARDIOGENIC STEM CELLS FOR SIGNALING STUDIES$0
U54 · FY2001 · GM
MOLECULAR BASIS FOR HYPOPLASTIC HEART SYNDROMES$1,079,875
P50 · FY2000 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC MUSCLE DEVELOPMENT$312,000
R37 · FY2000 · HL
TRANSCRIPTIONAL CONTROL OF CARDIAC HYPERTROPHY$312,000
R01 · FY2000 · HL
CORE--MOUSE LABORATORY$177,404
P50 · FY2000 · HL
TRANSCRIPTIONAL CONTROL OF VENTRICULAR DEVELOPMENT$177,402
P50 · FY2000 · HL